2004 news releases and statements

17/12/2004
Consultation is at heart of Review of Pharmaceutical Industry Code of Practice
09/12/2004
Stem cell research provides fresh hope for heart diease patients
02/12/2004
Pre-budget report: ABPI response
23/11/2004
Animal extremism: changes in law announced in Queen's speech
03/11/2004
7% price cut imposed on prescription medicines in new PPRS agreement
26/10/2004
New directory helps patients find out about health & medicines
25/10/2004
Pharmaceutical R&D remains vital to Britain
21/10/2004
Pharmaceutical trade balance growth - but imports are rising
20/10/2004
Education reforms must support science, says ABPI
05/10/2004
Handy Guide Explains ABPI Code Of Practice To NHS Managers
29/09/2004
European proposals on children's medicines do not go far enough, says ABPI
20/09/2004
Key recommendations to improve healthcare for patients put to Select Committee
07/09/2004
Animal Statistics: More Potential Medicines In Development
25/08/2004
ABPI welcomes new NICE Guidance on hypertension
24/08/2004
Counterfeit Medicine: ABPI Statement
02/08/2004
New ABPI Director General Named
02/08/2004
Faster information on new medicines for health service
30/07/2004
ABPI Response to government announcement on animal extremism legislation
28/07/2004
Pharmaceutical Companies establish million pound annual fund for animal research science skills training in UK academia
15/07/2004
Welcome For Government Spending Review
15/07/2004
Framework Will Help NHS And Pharmaceutical Industry To Work In Partnership To Help Patients
02/07/2004
Booklet examines ethics of using animals and medicines research
01/07/2004
New standards for pharmaceutical leaders of tomorrow
29/06/2004
New body will boost clinical trials in Uk, says ABPI
18/06/2004
ABPI welcomes Select Commitee inquiry into pharmaceutical industry
14/06/2004
New plans to ensure patients get NICE-recommended medicines are welcomed by industry
14/06/2004
ABPI response to SMF paper on parallel trade
10/06/2004
Handbook provides quick reference on healthcare
24/05/2004
Childhood leukaemia deaths set to drop further as new medicines are developed, report says
21/05/2004
New animal research centre gets warm welcome from pharmaceutical industry
19/05/2004
Pharmaceutical Industry trade surplus higher than expected
19/05/2004
Government's innovative plans threatened by lack of qualified R&D staff
12/05/2004
NICE and ABPI make progress on release of confidential data
10/05/2004
Recruiting patients for clinical trials remains a challenge
19/04/2004
ABPI regrets delayed european legislation for children's medicines
24/03/2004
Huge progress in heart disease treatment applauded by ABPI
24/03/2004
ABPI applauds government increase in targeted research funding
18/03/2004
UK-based Pharmaceutical industry challenges government to help create more young scientists
16/03/2004
£76 million research collaboration welcomed
16/03/2004
ABPI welcomes government's commitement to innovation
15/03/2004
NHS spends far less on innovative medicine than people believe, survey shows
12/02/2004
Professor Jones appointed to WHO commission
27/01/2004
Cambridge primate facility decision: ABPI statement
23/01/2004
Pharmaceutical company's investment 'is vote of confidence' in UK
22/01/2004
Parallel trade strikes at industry's ability to invest in search for new medicines, seminar told
21/01/2004
New directory will aid journalists, says ABPI
06/01/2004
Wholehearted welcome for judgement in Parallel Trade Case

Print this page

Get in touch

Please choose the subject of your enquiry from the list below:

Enter the above code here:

Can't read? Try different words.

Submit

I am happy for ABPI to keep my details on file and to send me details of future ABPI work and services. ABPI will not sell your data to any third party or send you any information about products or services that ABPI has no direct connection with.

The Association of the British Pharmaceutical Industry

7th floor, Southside, 105 Victoria Street,
London, SW1E 6QT
Telephone +44 (0) 870 890 4333
ABPI Cymru Wales
ABPI Northern Ireland
ABPI Scotland

The Prescription Medicines Code of Practice Authority (PMCPA) is responsible for administering the ABPI Code of Practice for the Pharmaceutical Industry at arm's length of the ABPI itself.

The Office of Health Economics (OHE) provides independent research, advisory and consultancy services on policy implications and economic issues within the pharmaceutical, health care and biotechnology sectors.